Shopping Cart 0
Cart Subtotal
AED 0

Receptor Tyrosine Protein Kinase ERBB 3 Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 8368

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 9102

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 10460

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 10460

Details

According to 99Strategy, the Global Receptor Tyrosine Protein Kinase ERBB 3 Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Receptor Tyrosine Protein Kinase ERBB 3 market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

AstraZeneca Plc

AVEO Pharmaceuticals, Inc.

Etubics Corporation

F. Hoffmann-La Roche Ltd.

GamaMabs Pharma S.A.

GlaxoSmithKline Plc

Hanmi Pharmaceuticals, Co. Ltd.

ImmunoGen, Inc.

Kolltan Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc.

Merus B.V.

Novartis AG

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.

Sorrento Therapeutics, Inc.

Symphogen A/S

Takis S.r.l.

Key Product Type

BA-0702

CDX-3379

Elgemtumab

ETBX-031

Others

Market by Application

Non-Small Cell Carcinoma

Solid Tumor

Melanoma

Colorectal Cancer

Others

Main Aspects covered in the Report

Overview of the Receptor Tyrosine Protein Kinase ERBB 3 market including production, consumption, status & forecast and market growth

2015-2018 historical data and 2019-2025 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

READ MORE

Table Of Content

Scope

Table of Content

1 Industrial Chain Overview

1.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry

1.1.1 Overview

1.1.2 Characteristics of Receptor Tyrosine Protein Kinase ERBB 3

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 BA-0702

1.3.2 CDX-3379

1.3.3 Elgemtumab

1.3.4 ETBX-031

1.3.5 Others

1.4 End-Use List

1.4.1 Demand in Non-Small Cell Carcinoma

1.4.2 Demand in Solid Tumor

1.4.3 Demand in Melanoma

1.4.4 Demand in Colorectal Cancer

1.4.5 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2015-2025

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

2.1.2 Global Consumption

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

2.2.1.2 North America

2.2.1.3 South America

2.2.1.4 Europe

2.2.1.5 Middle East & Africa

2.2.2 Consumption

2.2.2.1 Asia-Pacific

2.2.2.2 North America

2.2.2.3 South America

2.2.2.4 Europe

2.2.2.5 Middle East & Africa

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

3.2 Manufacturers List

3.2.1 AstraZeneca Plc Overview

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 AVEO Pharmaceuticals, Inc. Overview

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Etubics Corporation Overview

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 F. Hoffmann-La Roche Ltd. Overview

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 GamaMabs Pharma S.A. Overview

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 GlaxoSmithKline Plc Overview

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Hanmi Pharmaceuticals, Co. Ltd. Overview

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 ImmunoGen, Inc. Overview

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Kolltan Pharmaceuticals, Inc. Overview

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Merrimack Pharmaceuticals, Inc. Overview

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Merus B.V. Overview

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Novartis AG Overview

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Overview

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Sihuan Pharmaceutical Holdings Group Ltd. Overview

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Sorrento Therapeutics, Inc. Overview

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Symphogen A/S Overview

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Takis S.r.l. Overview

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

5.2 Segment Subdivision by Product Type

5.2.1 Market in BA-0702

5.2.1.1 Market Size

5.2.1.2 Situation & Development

5.2.2 Market in CDX-3379

5.2.2.1 Market Size

5.2.2.2 Situation & Development

5.2.3 Market in Elgemtumab

5.2.3.1 Market Size

5.2.3.2 Situation & Development

5.2.4 Market in ETBX-031

5.2.4.1 Market Size

5.2.4.2 Situation & Development

5.2.5 Market in Others

5.2.5.1 Market Size

5.2.5.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

6.2 Segment Subdivision

6.2.1 Market in Non-Small Cell Carcinoma

6.2.1.1 Market Size

6.2.1.2 Situation & Development

6.2.2 Market in Solid Tumor

6.2.2.1 Market Size

6.2.2.2 Situation & Development

6.2.3 Market in Melanoma

6.2.3.1 Market Size

6.2.3.2 Situation & Development

6.2.4 Market in Colorectal Cancer

6.2.4.1 Market Size

6.2.4.2 Situation & Development

6.2.5 Market in Others

6.2.5.1 Market Size

6.2.5.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

7.2 Consumption Forecast

7.2.1 Product Type Forecast

7.2.2 End-Use Forecast

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

10 Research Conclusion


List Of Figure

Figure Receptor Tyrosine Protein Kinase ERBB 3 Picture List

Figure Global Market Size and Forecast with Growth Rate, 2015-2025

Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Global Production Volume Share by Manufacturers in 2019, in Volume

Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

Figure Global Market Amount and Growth Rate in BA-0702, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in BA-0702, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in CDX-3379, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in CDX-3379, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Elgemtumab, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Elgemtumab, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in ETBX-031, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in ETBX-031, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Non-Small Cell Carcinoma, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Non-Small Cell Carcinoma, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Solid Tumor, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Solid Tumor, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Melanoma, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Melanoma, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Colorectal Cancer, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Colorectal Cancer, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume


List Of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

Table AstraZeneca Plc Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of AstraZeneca Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table AVEO Pharmaceuticals, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of AVEO Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Etubics Corporation Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Etubics Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of F. Hoffmann-La Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GamaMabs Pharma S.A. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of GamaMabs Pharma S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GlaxoSmithKline Plc Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of GlaxoSmithKline Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Hanmi Pharmaceuticals, Co. Ltd. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Hanmi Pharmaceuticals, Co. Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ImmunoGen, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of ImmunoGen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Kolltan Pharmaceuticals, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Kolltan Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merrimack Pharmaceuticals, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Merrimack Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merus B.V. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Merus B.V. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Novartis AG Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sihuan Pharmaceutical Holdings Group Ltd. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Sihuan Pharmaceutical Holdings Group Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sorrento Therapeutics, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Sorrento Therapeutics, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Symphogen A/S Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Symphogen A/S (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Takis S.r.l. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Takis S.r.l. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

Table Global Market Forecast by Region Segment 2019-2025, in Million USD

Table Global Market Forecast by Region Segment 2019-2025, in Volume

Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

Table Global Market Volume by Product Type Segment 2019-2025, in Volume

Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

Table Global Market Volume by End-Use Segment 2019-2025, in Volume

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

According to 99Strategy, the Global Receptor Tyrosine Protein Kinase ERBB 3 Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Receptor Tyrosine Protein Kinase ERBB 3 market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

AstraZeneca Plc

AVEO Pharmaceuticals, Inc.

Etubics Corporation

F. Hoffmann-La Roche Ltd.

GamaMabs Pharma S.A.

GlaxoSmithKline Plc

Hanmi Pharmaceuticals, Co. Ltd.

ImmunoGen, Inc.

Kolltan Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc.

Merus B.V.

Novartis AG

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.

Sorrento Therapeutics, Inc.

Symphogen A/S

Takis S.r.l.

Key Product Type

BA-0702

CDX-3379

Elgemtumab

ETBX-031

Others

Market by Application

Non-Small Cell Carcinoma

Solid Tumor

Melanoma

Colorectal Cancer

Others

Main Aspects covered in the Report

Overview of the Receptor Tyrosine Protein Kinase ERBB 3 market including production, consumption, status & forecast and market growth

2015-2018 historical data and 2019-2025 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

READ MORE

Scope

Table of Content

1 Industrial Chain Overview

1.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry

1.1.1 Overview

1.1.2 Characteristics of Receptor Tyrosine Protein Kinase ERBB 3

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 BA-0702

1.3.2 CDX-3379

1.3.3 Elgemtumab

1.3.4 ETBX-031

1.3.5 Others

1.4 End-Use List

1.4.1 Demand in Non-Small Cell Carcinoma

1.4.2 Demand in Solid Tumor

1.4.3 Demand in Melanoma

1.4.4 Demand in Colorectal Cancer

1.4.5 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2015-2025

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

2.1.2 Global Consumption

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

2.2.1.2 North America

2.2.1.3 South America

2.2.1.4 Europe

2.2.1.5 Middle East & Africa

2.2.2 Consumption

2.2.2.1 Asia-Pacific

2.2.2.2 North America

2.2.2.3 South America

2.2.2.4 Europe

2.2.2.5 Middle East & Africa

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

3.2 Manufacturers List

3.2.1 AstraZeneca Plc Overview

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 AVEO Pharmaceuticals, Inc. Overview

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Etubics Corporation Overview

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 F. Hoffmann-La Roche Ltd. Overview

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 GamaMabs Pharma S.A. Overview

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 GlaxoSmithKline Plc Overview

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Hanmi Pharmaceuticals, Co. Ltd. Overview

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 ImmunoGen, Inc. Overview

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Kolltan Pharmaceuticals, Inc. Overview

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Merrimack Pharmaceuticals, Inc. Overview

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Merus B.V. Overview

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Novartis AG Overview

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Overview

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Sihuan Pharmaceutical Holdings Group Ltd. Overview

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Sorrento Therapeutics, Inc. Overview

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Symphogen A/S Overview

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Takis S.r.l. Overview

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

5.2 Segment Subdivision by Product Type

5.2.1 Market in BA-0702

5.2.1.1 Market Size

5.2.1.2 Situation & Development

5.2.2 Market in CDX-3379

5.2.2.1 Market Size

5.2.2.2 Situation & Development

5.2.3 Market in Elgemtumab

5.2.3.1 Market Size

5.2.3.2 Situation & Development

5.2.4 Market in ETBX-031

5.2.4.1 Market Size

5.2.4.2 Situation & Development

5.2.5 Market in Others

5.2.5.1 Market Size

5.2.5.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

6.2 Segment Subdivision

6.2.1 Market in Non-Small Cell Carcinoma

6.2.1.1 Market Size

6.2.1.2 Situation & Development

6.2.2 Market in Solid Tumor

6.2.2.1 Market Size

6.2.2.2 Situation & Development

6.2.3 Market in Melanoma

6.2.3.1 Market Size

6.2.3.2 Situation & Development

6.2.4 Market in Colorectal Cancer

6.2.4.1 Market Size

6.2.4.2 Situation & Development

6.2.5 Market in Others

6.2.5.1 Market Size

6.2.5.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

7.2 Consumption Forecast

7.2.1 Product Type Forecast

7.2.2 End-Use Forecast

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

10 Research Conclusion


List Of Figure

Figure Receptor Tyrosine Protein Kinase ERBB 3 Picture List

Figure Global Market Size and Forecast with Growth Rate, 2015-2025

Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

Figure Global Production Volume Share by Manufacturers in 2019, in Volume

Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

Figure Global Market Amount and Growth Rate in BA-0702, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in BA-0702, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in CDX-3379, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in CDX-3379, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Elgemtumab, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Elgemtumab, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in ETBX-031, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in ETBX-031, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Non-Small Cell Carcinoma, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Non-Small Cell Carcinoma, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Solid Tumor, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Solid Tumor, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Melanoma, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Melanoma, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Colorectal Cancer, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Colorectal Cancer, 2015-2018, in Volume

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume


List Of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

Table AstraZeneca Plc Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of AstraZeneca Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table AVEO Pharmaceuticals, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of AVEO Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Etubics Corporation Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Etubics Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Ltd. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of F. Hoffmann-La Roche Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GamaMabs Pharma S.A. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of GamaMabs Pharma S.A. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GlaxoSmithKline Plc Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of GlaxoSmithKline Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Hanmi Pharmaceuticals, Co. Ltd. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Hanmi Pharmaceuticals, Co. Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ImmunoGen, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of ImmunoGen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Kolltan Pharmaceuticals, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Kolltan Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merrimack Pharmaceuticals, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Merrimack Pharmaceuticals, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merus B.V. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Merus B.V. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Novartis AG Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Novartis AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sihuan Pharmaceutical Holdings Group Ltd. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Sihuan Pharmaceutical Holdings Group Ltd. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sorrento Therapeutics, Inc. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Sorrento Therapeutics, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Symphogen A/S Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Symphogen A/S (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Takis S.r.l. Overview List

Table Receptor Tyrosine Protein Kinase ERBB 3 Business Operation of Takis S.r.l. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

Table Global Market Forecast by Region Segment 2019-2025, in Million USD

Table Global Market Forecast by Region Segment 2019-2025, in Volume

Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

Table Global Market Volume by Product Type Segment 2019-2025, in Volume

Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

Table Global Market Volume by End-Use Segment 2019-2025, in Volume

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS